Jiangsu Xinyi Taihe Chemical Co., Ltd. announced that it will receive $2,172,600 (CNY 13,305,200) in an equity round of funding from new investor, SDS Biotech K.K. on March 10, 2014. The investor will acquire 15% stake in the company through this transaction. As part of the transaction, $561,500 (CNY 3,438,700) will be transferred to the registered capital of the company and the balance will be transferred to its reserve. On the same date, the transaction was approved by the board of directors of the investor. The transaction is expected to close on March 12, 2014. The capital of the company will increase from $3,182,000 (CNY 19,486,800) to $3,743,500 (CNY 22,925,500) on completion of the transaction. The company reported total assets of CNY 73,786,700, total liabilities of CNY 40,997,400, total shareholders' equity of CNY 32,789,200, revenues of CNY 115,124,700, operating profit of CNY 3,787,200, total profit of CNY 3,827,200, and net profit of CNY 2,858,400 for the year ended December 31, 2013. The conversion was made through www.oanda.com on March 10, 2014.

On April 3, 2014, the Xinyi Administration Bureau for Industry and Commerce approved the transaction.

On April 16, 2014, Jiangsu Xinyi Taihe Chemical Co., Ltd. closed the transaction. The company obtained a new business license issued by the Xuzhou Administration for Industry and Commerce.